Surface plasmon resonance biosensor for the detection of VEGFR-1--a protein marker of myelodysplastic syndromes

Anal Bioanal Chem. 2012 Jan;402(1):381-7. doi: 10.1007/s00216-011-5395-3. Epub 2011 Sep 20.

Abstract

The surface plasmon resonance (SPR) biosensor system with dispersionless microfluidics for the direct and label-free detection of a soluble vascular endothelial growth factor receptor (sVEGFR-1) is described. The detection approach takes advantage of an affinity interaction between sVEGFR-1 and its ligand, vascular endothelial growth factor (VEGF-A), which is covalently immobilized on the surface of the SPR sensor. The ability of the immobilized VEGF-A to specifically bind the sVEGFR-1 receptor is demonstrated in a buffer. The detection of sVEGFR-1 in 2% human blood plasma is carried out by using the sequential injection approach. The detection limit of 25 ng/mL is achieved. In addition, we demonstrate that the functional surface of the sensor can be regenerated for repeated use.

Publication types

  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers / blood
  • Biosensing Techniques / methods*
  • Humans
  • Myelodysplastic Syndromes / blood*
  • Myelodysplastic Syndromes / diagnosis
  • Myelodysplastic Syndromes / metabolism
  • Protein Binding
  • Surface Plasmon Resonance / methods*
  • Vascular Endothelial Growth Factor A / blood
  • Vascular Endothelial Growth Factor A / metabolism
  • Vascular Endothelial Growth Factor Receptor-1 / blood*
  • Vascular Endothelial Growth Factor Receptor-1 / metabolism

Substances

  • Biomarkers
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factor Receptor-1